The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism

Psychopharmacology

Volumn 170, Issue 3, 2003, Pages 309-319

  Higgins, Guy A ^a,b   Enderlin, Michel ^a   Haman, Marie ^a   Fletcher, Paul J ^c  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b MERCK RESEARCH LABORATORIES   (United States)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

5 Choice serial reaction time task; 5 HT2C receptor; Dizocilpine; DRL24; Impulsivity; Response inhibition; Ro 63 1908; SB242,084

Indexed keywords

6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; RO 63 1908; SB 215505; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG; AMINOPYRIDINE DERIVATIVE; DIZOCILPINE MALEATE; FLUOROBENZENE; INDOLE DERIVATIVE; NEUROPROTECTIVE AGENT; PIPERIDINE DERIVATIVE; SEROTONIN ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFECT; HYPERACTIVITY; IMPULSIVENESS; MALE; MOTOR PERFORMANCE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RAT; RECEPTOR BLOCKING; REINFORCEMENT; RESPONSE TIME; SEROTONINERGIC SYSTEM; STIMULUS RESPONSE; TASK PERFORMANCE; ANIMAL; DRUG ANTAGONISM; DRUG INTERACTION; MOTOR ACTIVITY; REACTION TIME;

AMINOPYRIDINES; ANIMALS; DIZOCILPINE MALEATE; DRUG INTERACTIONS; FLUOROBENZENES; IMPULSIVE BEHAVIOR; INDOLES; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PIPERIDINES; RATS; REACTION TIME; RECEPTORS, N-METHYL-D-ASPARTATE; SEROTONIN ANTAGONISTS;

EID: 0242683981     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1549-0     Document Type: Article

References (64)

1. Aghajanian GK, Marek GJ (2000) Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Rev 31:302-312
2. Bakshi V, Geyer MA (1997) Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. J Pharmacol Exp Ther 283:666-674
3. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152
4. Breese GR, Knapp DJ, Moy SS (2002) Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness. Neurosci Biobehav Rev 26:441-455
5. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction time task in rats: implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361-380
6. Cole BJ, Robbins TW (1987) Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology 91:458-466
7. Cole BJ, Robbins TW (1989) Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 33:165-179
8. Dalley JW, Theobald DE, Eagle DM, Passetti F, Robbins TW (2002) Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 26:716-728
9. Danysz W, Zajackowski W, Parsons CG (1995) Modulation of learning processes by ionotropic glutamate receptor ligands. Behav Pharmacol 6:455-474
10. 2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38:1195-1205
11. Fletcher PJ (1995) Effects of combined or separate 5,7- dihydroxytryptamine lesions of the dorsal and median raphe nuclei on responding maintained by a DRL 20 s schedule of food reinforcement. Brain Res 675:45-54
12. 2C receptor antagonist SB242,084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27:576-586
13. Fray PJ, Sahakian BJ, Robbins TW, Koob GF, Iversen SD (1980) An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of D-amphetamine and apomorphine. Psychopharmacology 69:253-259
14. Gill R, Alanine A, Bourson A, Buttelman B, Fischer G, Heitz M-P, Kew JNC, Levet-Trafit B, Lorez H-P, Malherbe P, Miss M-T, Mutel V, Pinard E, Roever S, Schmitt M, Trube G, Wybrecht R, Wyler R, Kemp JA (2002) Pharmacological characterisation of Ro 63-1908, a novel sub-type selective NMDA antagonist. J Pharmacol Exp Ther 302:940-948
15. Grottick AJ, Higgins GA (2000) Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res 117:197-208
16. 2C receptors on cocaine-and food-maintained behavior. J Pharmacol Exp Ther 295:1183-1191
17. Haiser LK, Tecott LH (2000) A paradoxical locomotor response in serotonin 5-HT2c receptor mutant mice. J Neurosci 20:RC711-RC715)
18. Harrison AA, Everitt BJ, Robbins TW (1997) Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology 133:329-342
19. 2 agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine. Br J Pharmacol 133:459-466
20. Higgins GA, Ballard TM, Huwyler J, Kemp JA, Gill R (2003) Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition. Neuropharmacology 44:324-341
21. 2C/2B receptor antagonists: neurochemical and behavioural studies. Neuropharmacology 39:2318-2328
22. Jakab RL, Goldman-Rakic PS (1998) 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 95:735-740
23. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
24. 2A antagonist with a favorable CNS profile. J Pharmacol Exp Ther 277:968-981
25. 2C receptor antagonist. Neuropharmacology 36:609-620
26. 2B receptor mediated. Neuropharmacology 37:1603-1610
27. 2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 39:471-481
28. Koskinen T, Ruotsalainen S, Sirvio J (2000b) The 5-HT(2) receptor activation enhances impulsive responding without increasing motor activity in rats. Pharmacol Biochem Behav 66:729-738
29. 3H] MDL100,907. Naunyn Schmiedebergs Arch Pharmacol 356:446-454
30. Loscher W, Honack D (1992) The behavioural effects of MK801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur J Pharmacology 215:199-208
31. 2A receptors attenuates the behavioral effects of cocaine in rats. J Pharmacol Exp Ther 297:357-363
32. Mansbach RS, Geyer MA (1991) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2:299-308
33. 1 adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacology 367:197-206
34. Martin P, Waters N, Waters S, Carlsson A, Carlsson ML (1997) MK-801-induced hyperlocomotion: differential effects of M100,907, SDZ PSD 958 and raclopride. Eur J Pharmacol 335:107-116
35. Mathe JM, Nomikos GG, Hildebrand BE, Hertel P, Svensson TH (1996) Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur J Pharmacol 309:1-11
36. 2A receptors. Eur J Pharmacol 280:R9-R11
37. Meltzer HY (1999) The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21:106S-115S
38. 2A sites for PCP-induced locomotion in the rat. Eur J Neuroscience 11:4419-4432
39. 2A antagonist. Behav Brain Res 73:163-167
40. Muir JL, Everitt BJ, Robbins TW (1996) The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex 6:470-481
41. 3H] Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J Neurochem 70:2147-2155
42. Passetti F, Dalley JW, Robbins TW (2003) Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacology 165:136-145
43. 2C receptors. Mol Brain Res 23:163-178
44. Puumala T, Sirvio J (1998) Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task. Neuroscience 83:489-499
45. 2C receptor antagonist. Br J Pharmacol 126:572-574
46. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163:362-380
47. Rocha BA, Goulding EH, O'Dell LE, Mead AN, Coufal NG, Parsons LH, Tecott LH (2002) Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J Neuroscience 22:10039-10045
48. Routsalainen S, Sirvio J, Jakala P, Puumala T, MacDonald E, Riekkinen P (1997) Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks. Eur Neuropsychopharmacol 7:99-108
49. Rudolf GD, Cronin CA, Landwehrmeyer GB, Standaert DG, Penney JB, Young AB (1996) Expression of N-methyl-D-aspartate glutamate receptor subunits in the prefrontal cortex of the rat. Neuroscience 73:417-427
50. 2A receptors in antipsychotic activity. Life Sci 56:2209-2222
51. Sanger DJ (1992) NMDA antagonists disrupt timing behaviour in rats. Behav Pharmacol 3:593-600
52. Sanger DJ, Key M, Blackman DE (1974) Differential effects of chlordiazepoxide and D-amphetamine on responding maintained by a DRL schedule of reinforcement. Psychopharmacologia 38:159-171
53. Stephens DN, Cole BJ (1996) AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks. Psychopharmacology 126:249-259
54. Tricklebank MD, Singh L, Oles RJ, Preston C, Iversen SD (1989) The behavioural effects of MK801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167:127-135
55. Tzechentke TM, Schmidt WJ (1998) Does the noncompetitive NMDA antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration? Trends Pharmacol Sci 19:447-451
56. 2 receptor antagonist ketanserin. Eur J Pharmacol 287:201-205
57. 2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology 20:311-321
58. 2A receptor inverse agonists as antipsychotics. J Pharmacol Exp Ther 299:268-276
59. Welzl H, Berz S, Battig K (1991) The effects of the noncompetitive NMDA receptor antagonist MK801 on DRL performance in rats. Psychobiology 19:211-216
60. Wenzel A, Fritschy JM, Mohler H, Benke D (1997) NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. J Neurochem 68:469-478
61. Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw Hill, New York
62. Willetts J, Balster RL, Leander JD (1990) The behavioural pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11:423-428
63. Wogar MA, Bradshaw CM, Szabadi E (1992) Impaired acquisition of temporal differentiation performance following lesions of the ascending 5-hydroxytryptaminergic pathways. Psychopharmacology 107:373-378
64. Yamada S, Harano M, Annoh N, Nakamura K, Tanaka M (1999) Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats. Biol Psychiatry 46:832-838